Study of Oral Darinaparsin in Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
This study is a Phase I, dose escalation study of oral darinaparsin for the treatment of
advanced solid tumors. Eligible patients could have received any amount of previous therapy.